Leaderboards/Health Promotion and Cardiovascular Prevention

Health Promotion and Cardiovascular Prevention

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Stephanie M. Lopez-Neyman
Texas Woman's University
2
Hannah Whittaker
Imperial College London
3
Issam Motairek
Cleveland Clinic
4
Shaan Khurshid
Massachusetts General Hospital
5
Emily L. Graul
Emory University
6
Ya‐Chin Huang
Cambridge Health Alliance
7
Tamar I. de Vries
Heidelberg University
8
Yanqiang Lu
University of South China
9
Zahra Jamali
Rafsanjan University of Medical Sciences
10
Valerie Kuan
University College London

Rising Stars Papers

1
Associations of “Weekend Warrior” Physical Activity With Incident Disease and Cardiometabolic Health
Circulation|2024
69 cit.
2
Metabolic syndrome: a population-based study of prevalence and risk factors
Scientific Reports|2024
56 cit.
3
Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease
Journal of the American College of Cardiology|2024
45 cit.
4
Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data
Respiratory Research|2024
12 cit.
5
Frequency of Electrocardiogram-Defined Cardiac Conduction Disorders in a Multi-Institutional Primary Care Cohort
JACC Advances|2024
12 cit.
6
A large study of metabolomics reveals common and distinct metabolic biomarkers for type 2 diabetes, coronary heart disease, and stroke
American Journal of Epidemiology|2024
11 cit.
7
Another piece in the puzzle of atrial fibrillation risk: clinical, genetic, and electrocardiogram-based artificial intelligence
European Heart Journal|2024
10 cit.
8
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
Thorax|2025
9 cit.
9
Historical neighborhood redlining and bystander CPR disparities in out-of-hospital cardiac arrest
Resuscitation|2024
8 cit.
10
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study
BMC Pulmonary Medicine|2024
4 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Seung-lyeal Jeong
National Health Insurance Service
2
on behalf of the EUROASPIRE investi
Unknown
3
Marcelo Coca Perraillon
Colorado School of Public Health
4
Simone Binno
University of Parma
5
Tianwen Lai
Lanzhou Jiaotong University
6
Fahd I. Al Rumaih
King Saud University
7
Natalie Terzikhan
Erasmus MC
8
Tracie Sullivan
COPD Foundation
9
Derek Miketinas
Texas Woman's University
10
Jane Desborough
Australian National University

Emerging Leaders Papers

1
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019
Frontiers in Public Health|2022
135 cit.
2
The Rotterdam Study. Design update and major findings between 2020 and 2024
European Journal of Epidemiology|2024
127 cit.
3
Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011–2018
Scientific Reports|2022
116 cit.
4
The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation
Theranostics|2023
80 cit.
5
Epithelial SIRT6 governs IL-17A pathogenicity and drives allergic airway inflammation and remodeling
Nature Communications|2023
48 cit.
6
Time to diagnosis for a rare disease: managing medical uncertainty. A qualitative study
Orphanet Journal of Rare Diseases|2024
37 cit.
7
Adoption and Value of the Medicare Annual Wellness Visit: A Mixed-Methods Study
Medical Care Research and Review|2023
24 cit.
8
Trends in the prevalence of conduct disorder from 1990 to 2019: Findings from the Global Burden of Disease Study 2019
Psychiatry Research|2022
17 cit.
9
Usual dietary fibre intake according to diabetes status in USA adults – NHANES 2013–2018
British Journal Of Nutrition|2023
15 cit.
10
Diagnostic delay of sarcoidosis: an integrated systematic review
Orphanet Journal of Rare Diseases|2024
14 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Richard A. Kronmal
University of Washington
2
Jeremy Grimshaw
Centre for Global Health Research
3
David C. Atkins
Lynn University
4
Melanie Nichols
Deakin University
5
Alastair Gray
University of Oxford
6
Clyde W. Yancy
Northwestern Memorial Hospital
7
Arno W. Hoes
University Medical Center Utrecht
8
Massimo Piepoli
University of Milan
9
José Luis Zamorano
Centro de Investigación en Red en Enfermedades Cardiovasculares
10
Felix E. Moore
National Heart Institute

Current Senior Leaders Papers

1
2013 ACCF/AHA Guideline for the Management of Heart Failure
Journal of the American College of Cardiology|2013
12.6k cit.
2
Grading quality of evidence and strength of recommendations
BMJ|2004
8.5k cit.
3
2016 European Guidelines on cardiovascular disease prevention in clinical practice
European Heart Journal|2016
6.5k cit.
4
2015 ESC Guidelines for the management of infective endocarditis
European Heart Journal|2015
5k cit.
5
2014 ESC/EACTS Guidelines on myocardial revascularization
European Journal of Cardio-Thoracic Surgery|2014
4.2k cit.
6
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Journal of the American College of Cardiology|2017
3.4k cit.
7
What is an adequate sample size? Operationalising data saturation for theory-based interview studies
Psychology and Health|2009
3.4k cit.
8
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Circulation|2013
3.3k cit.
9
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Journal of the American College of Cardiology|2014
3k cit.
10
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
New England Journal of Medicine|2008
3k cit.

Reagents for Health Promotion and Cardiovascular Prevention

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

GDF15/MIC1 (E5Q8Q) Rabbit Monoclonal Antibody (BSA and Azide Free)

#70830$865
View Evidence →
Cell Signaling TechnologyEvidence 66

Cleaved Caspase-3 (Asp175) (5A1E) Rabbit Monoclonal Antibody (Biotinylated)

#9654$587
View Evidence →
Cell Signaling TechnologyEvidence 65

SARS-CoV-2 Spike Protein (RBD) Matched Antibody Pair

#92221$1,726
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 60

NCKIPSD (E6Z3N) Rabbit Monoclonal Antibody

#89661$161,351
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-Stat6 (Tyr641) (D8S9Y) Rabbit Monoclonal Antibody (BSA and Azide Free)

#46186$898
View Evidence →
Cell Signaling TechnologyEvidence 66

Ubiquityl-Histone H2A (Lys119) (D27C4) Rabbit Monoclonal Antibody (BSA and Azide Free)

#45772$898
View Evidence →